---
layout: minimal-medicine
title: Triptorelin
---

# Triptorelin
### Generic Name
Triptorelin

### Usage

Triptorelin is a gonadotropin-releasing hormone (GnRH) agonist.  Its primary use is in the palliative treatment of advanced prostate cancer. By suppressing the production of testosterone, it helps slow the growth of prostate cancer cells.  Triptorelin also treats central precocious puberty, a condition where children enter puberty too early.  In assisted reproductive technologies (ART), it's used adjunctively to manage controlled ovarian hyperstimulation, helping to prevent premature ovulation.  Importantly, Triptorelin is sometimes used off-label for conditions like endometriosis and endometrial stromal sarcoma, although its efficacy and safety in these contexts are not fully established by extensive clinical trials.  Note that the use of Triptorelin to treat paraphilia or hypersexuality is also off-label and should only be considered under strict medical supervision.


### Dosage

Triptorelin dosage varies significantly depending on the condition being treated and the route of administration (intramuscular [IM] injection or subcutaneous [SubQ] injection).  Precise dosing must always be determined by a healthcare professional.

**Adults:**

* **Advanced Prostate Cancer (IM):**  Typical regimens include 3.75 mg once every 4 weeks, 11.25 mg every 12 weeks, or 22.5 mg every 24 weeks.
* **Controlled Ovarian Hyperstimulation for ART (SubQ):** Usually starts with 0.1 mg daily, beginning on day 2 or 3, or days 21-23 of the menstrual cycle.  The dose and duration are adjusted based on individual ovarian response, monitored via ultrasound and estradiol levels.
* **Off-label uses (e.g., Endometriosis, Endometrial Stromal Sarcoma):** Dosage varies greatly and is determined on a case-by-case basis by a medical professional; examples include 3.75mg every 4 or 6 weeks for endometriosis, or 3.75mg every 28 days for several months for endometrial stromal sarcoma.
* **Off-label use (Paraphilia/Hypersexuality):**  A test dose of 1 mg IM may be given initially, followed by monthly injections if tolerated. Subcutaneous administration may also be employed with 3.75mg monthly.


**Children (Central Precocious Puberty):**

* Extended-release injectable suspension: 22.5 mg once every 24 weeks. Treatment is discontinued at the appropriate age for the onset of puberty.  Use in children under 2 years old is not established.


**Dosage Adjustments:** No specific dosage adjustments are provided for hepatic or renal impairment in the manufacturer's labeling, but it is important to note that both conditions may increase systemic exposure to Triptorelin.  Healthcare providers should carefully monitor patients with these conditions.



### Side Effects

**Common Side Effects (frequency >10%):**

* Headache
* Hot flashes
* Injection site pain/erythema
* Increased serum glucose (in prostate cancer treatment)
* Decreased hemoglobin/RBC count (in prostate cancer treatment)
* Increased liver enzymes (in prostate cancer treatment)


**Less Common but Serious Side Effects (frequency 1-10% or less, but potentially severe):**

* Allergic reactions (including angioedema and anaphylaxis)
* Cardiovascular events (myocardial infarction, stroke)
* Osteoporosis and fractures
* Psychiatric effects (depression, mood swings, anxiety)
* Ovarian hyperstimulation syndrome (in ART)
* Pituitary apoplexy


If you experience any adverse effects, particularly serious ones, consult your doctor immediately.

### How it Works

Triptorelin is a GnRH agonist.  It initially stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).  However, with prolonged use, it causes a down-regulation of GnRH receptors in the pituitary gland. This leads to a decrease in LH and FSH levels, subsequently suppressing the production of sex hormones (testosterone in men and estrogen in women). This hormonal suppression is crucial in treating prostate cancer and precocious puberty and helps manage ovarian stimulation in ART.


### Precautions

* **Contraindications:** Hypersensitivity to Triptorelin or other GnRH agonists; pregnancy; breastfeeding.
* **Interactions:** Concomitant use with hyperprolactinemic drugs is not recommended.
* **Warnings:** Increased risk of cardiovascular disease, osteoporosis, hyperglycemia, hypersensitivity reactions, ovarian hyperstimulation syndrome, pituitary apoplexy, and psychiatric effects.  Use caution in patients with risk factors for decreased bone mineral density.  Regular monitoring is necessary for patients using Triptorelin, especially those with pre-existing health conditions.
* **Pregnancy and Breastfeeding:** Triptorelin is categorized as Pregnancy Category X.  It's contraindicated during pregnancy and breastfeeding because it can harm the fetus.  For ART, pregnancy must be ruled out before treatment, and non-hormonal contraception is necessary until menses returns.

### FAQs

* **Q: How long does it take for Triptorelin to work?** A: The time it takes to see effects depends on the condition being treated. For prostate cancer, it typically takes 2-4 weeks for testosterone suppression.  In ART, effects are seen more quickly.
* **Q: How should I store Triptorelin?** A: Store as directed by your pharmacist or healthcare provider.
* **Q: Can I drink alcohol while taking Triptorelin?** A: Consult your doctor about potential interactions between Triptorelin and alcohol.
* **Q: What should I do if I miss a dose?** A: Contact your doctor immediately for guidance. Do not double the dose.
* **Q: Are there any long-term effects of Triptorelin?** A: Long-term use can increase the risk of osteoporosis and other adverse effects, necessitating careful monitoring.
* **Q:  Is Triptorelin suitable for everyone?** A: No, Triptorelin is not appropriate for everyone.  Individuals with specific allergies or medical conditions should discuss its suitability with their doctor.

**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice.  Always consult with a healthcare professional before starting or changing any medication, including Triptorelin.  They can assess your individual health status and determine the most appropriate treatment plan.
